Posts
-
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
-
Comparing Quality at Veterans and Civilian Hospitals
Veterans Affairs hospitals outperformed civilian hospitals on most measures of quality and patient safety, but scored lower on indicators of patient experience, according to new Northwestern Medicine research.
-
Stopping Violence, Before It Happens
Hans Breiter, ’88 MD, professor of Psychiatry and Behavioral Sciences, is leading the development of a radical, proactive approach to stopping violence using advanced mathematical models of human emotion.